Home / Latest Reports / Cancer Stem Cells Market

Cancer Stem Cells Market by Type, End User, Key Players and Regions - Global Industry Analysis & Forecast to 2027

Published On : August 2022 Pages : 154 Category: Pharma & Healthcare Report Code : HC0817421

Request Sample Inquiry Before Buying Request for Customization Check Discount

The global Cancer Stem Cells Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.

The report exhibit detail coverage of Cancer Stem Cells industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Cancer Stem Cells Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Cancer Stem Cells Market for 2017-2022.

Crystal Market Research envisions that the span of the Cancer Stem Cells Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.

Our research study analyses the size of the global market of Cancer Stem Cells in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Cancer Stem Cells Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.

To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Cancer Stem Cells Market on the basis of fabric, product, application, and region:

By Region

  • North America (US, Canada)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Mexico, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)

Competitive Analysis                    

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Merck KGaA
  • Bionomics
  • Thermo Fisher Scientific Inc.
  • AbbVie Inc.
  • Lonza
  • Miltenyi Biotec
  • PromoCell GmbH
  • Stemline Therapeutics
  • MacroGenics, Inc.
  • OncoMed Pharmaceuticals Inc.
  • STEMCELL Technologies Inc.
  • Irvine Scientificand BIOTIME Inc.

Market Classification

·        Cancer Stem Cells Market, By Type, Estimates and Forecast, 2017-2022 ($Million)

o   Breast Cancer

o   Blood Cancer

o   Lung Cancer

o   Brain Cancer

o   Colorectal Cancer

o   Pancreatic Cancer

o   Bladder Cancer

o   Liver Cancer

o   Others

·        Cancer Stem Cells Market, By End User, Estimates and Forecast, 2017-2022 ($Million)

o   Specialised Cancer Treatment Centers

o   Hospitals

o   Research Institutes & Labs

Table of Contents

1.     Introduction

1.1.  Report Description

1.2.  Research Methodology

1.2.1.     Data Mining

1.2.2.     Market Modeling and Forecasting

1.2.3.     Data Validation

1.2.4.     Industry Analysis

2.     Market Dashboard

3.     Market Overview

3.1.  Introduction

3.1.1.     Market Definition

3.1.2.     Market Segmentation

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

4.     Cancer Stem Cells Market, By Type

4.1.  Introduction

4.2.  Cancer Stem Cells Market and Market Growth Rate By Type (2017-2022)

4.3.  Breast Cancer

4.3.1.     Global Breast Cancer Market and Growth Rate (2017-2022)

4.3.  Blood Cancer

4.3.1.     Global Blood Cancer Market and Growth Rate (2017-2022)

4.3.  Lung Cancer

4.3.1.     Global Lung Cancer Market and Growth Rate (2017-2022)

4.3.  Brain Cancer

4.3.1.     Global Brain Cancer Market and Growth Rate (2017-2022)

4.3.  Colorectal Cancer

4.3.1.     Global Colorectal Cancer Market and Growth Rate (2017-2022)

4.3.  Pancreatic Cancer

4.3.1.     Global Pancreatic Cancer Market and Growth Rate (2017-2022)

4.3.  Bladder Cancer

4.3.1.     Global Bladder Cancer Market and Growth Rate (2017-2022)

4.3.  Liver Cancer

4.3.1.     Global Liver Cancer Market and Growth Rate (2017-2022)

4.3.  Others

4.3.1.     Global Others Market and Growth Rate (2017-2022)

5.     Cancer Stem Cells Market, By End User

5.1.  Introduction

5.2.  Cancer Stem Cells Market and Market Growth Rate By End User (2017-2022)

5.3.  Specialised Cancer Treatment Centers

5.3.1.     Global Specialised Cancer Treatment Centers Market and Growth Rate (2017-2022)

5.3.  Hospitals

5.3.1.     Global Hospitals Market and Growth Rate (2017-2022)

5.3.  Research Institutes & Labs

5.3.1.     Global Research Institutes & Labs Market and Growth Rate (2017-2022)

7.     Cancer Stem Cells Market, By Region

7.1.  Introduction

7.2.  Cancer Stem Cells Market and Growth Rate By Regions

6.3.  North America

7.3.1.     North America Cancer Stem Cells Market and Growth Rate (2017-2022))

7.3.2.     North America Cancer Stem Cells Market By Type (2017-2022)

7.3.2.     North America Cancer Stem Cells Market By End User (2017-2022)

7.3.4.     North America Cancer Stem Cells Market By Country (2017-2022)

7.3.5.     United States

7.3.5.1.United States Cancer Stem Cells Market and Growth Rate (2017-2022)

7.3.5.2.United States Cancer Stem Cells Market By Type (2017-2022)

7.3.5.2.United States Cancer Stem Cells Market By End User (2017-2022)

7.3.5.     Canada

7.3.5.1.Canada Cancer Stem Cells Market and Growth Rate (2017-2022)

7.3.5.2.Canada Cancer Stem Cells Market By Type (2017-2022)

7.3.5.2.Canada Cancer Stem Cells Market By End User (2017-2022)

6.3.  Europe

8.3.1.     Europe Cancer Stem Cells Market and Growth Rate (2017-2022))

8.3.2.     Europe Cancer Stem Cells Market By Type (2017-2022)

8.3.2.     Europe Cancer Stem Cells Market By End User (2017-2022)

8.3.4.     Europe Cancer Stem Cells Market By Country (2017-2022)

8.3.5.     Germany

8.3.5.1.Germany Cancer Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.Germany Cancer Stem Cells Market By Type (2017-2022)

8.3.5.2.Germany Cancer Stem Cells Market By End User (2017-2022)

8.3.5.     France

8.3.5.1.France Cancer Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.France Cancer Stem Cells Market By Type (2017-2022)

8.3.5.2.France Cancer Stem Cells Market By End User (2017-2022)

8.3.5.     UK

8.3.5.1.UK Cancer Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.UK Cancer Stem Cells Market By Type (2017-2022)

8.3.5.2.UK Cancer Stem Cells Market By End User (2017-2022)

8.3.5.     Russia

8.3.5.1.Russia Cancer Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.Russia Cancer Stem Cells Market By Type (2017-2022)

8.3.5.2.Russia Cancer Stem Cells Market By End User (2017-2022)

8.3.5.     Italy

8.3.5.1.Italy Cancer Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.Italy Cancer Stem Cells Market By Type (2017-2022)

8.3.5.2.Italy Cancer Stem Cells Market By End User (2017-2022)

8.3.5.     Rest of Europe

8.3.5.1.Rest of Europe Cancer Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.Rest of Europe Cancer Stem Cells Market By Type (2017-2022)

8.3.5.2.Rest of Europe Cancer Stem Cells Market By End User (2017-2022)

6.3.  Asia-Pacific

9.3.1.     Asia-Pacific Cancer Stem Cells Market and Growth Rate (2017-2022))

9.3.2.     Asia-Pacific Cancer Stem Cells Market By Type (2017-2022)

9.3.2.     Asia-Pacific Cancer Stem Cells Market By End User (2017-2022)

9.3.4.     Asia-Pacific Cancer Stem Cells Market By Country (2017-2022)

9.3.5.     China

9.3.5.1.China Cancer Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.China Cancer Stem Cells Market By Type (2017-2022)

9.3.5.2.China Cancer Stem Cells Market By End User (2017-2022)

9.3.5.     Japan

9.3.5.1.Japan Cancer Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.Japan Cancer Stem Cells Market By Type (2017-2022)

9.3.5.2.Japan Cancer Stem Cells Market By End User (2017-2022)

9.3.5.     Korea

9.3.5.1.Korea Cancer Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.Korea Cancer Stem Cells Market By Type (2017-2022)

9.3.5.2.Korea Cancer Stem Cells Market By End User (2017-2022)

9.3.5.     India

9.3.5.1.India Cancer Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.India Cancer Stem Cells Market By Type (2017-2022)

9.3.5.2.India Cancer Stem Cells Market By End User (2017-2022)

9.3.5.     Southeast Asia

9.3.5.1.Southeast Asia Cancer Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.Southeast Asia Cancer Stem Cells Market By Type (2017-2022)

9.3.5.2.Southeast Asia Cancer Stem Cells Market By End User (2017-2022)

9.3.5.     Rest of Asia-Pacific

9.3.5.1.Rest of Asia-Pacific Cancer Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.Rest of Asia-Pacific Cancer Stem Cells Market By Type (2017-2022)

9.3.5.2.Rest of Asia-Pacific Cancer Stem Cells Market By End User (2017-2022)

6.3.  South America

10.3.1.     South America Cancer Stem Cells Market and Growth Rate (2017-2022))

10.3.2.     South America Cancer Stem Cells Market By Type (2017-2022)

10.3.2.     South America Cancer Stem Cells Market By End User (2017-2022)

10.3.4.     South America Cancer Stem Cells Market By Country (2017-2022)

10.3.5.     Brazil

10.3.5.1.Brazil Cancer Stem Cells Market and Growth Rate (2017-2022)

10.3.5.2.Brazil Cancer Stem Cells Market By Type (2017-2022)

10.3.5.2.Brazil Cancer Stem Cells Market By End User (2017-2022)

10.3.5.     Mexico

10.3.5.1.Mexico Cancer Stem Cells Market and Growth Rate (2017-2022)

10.3.5.2.Mexico Cancer Stem Cells Market By Type (2017-2022)

10.3.5.2.Mexico Cancer Stem Cells Market By End User (2017-2022)

10.3.5.     Columbia

10.3.5.1.Columbia Cancer Stem Cells Market and Growth Rate (2017-2022)

10.3.5.2.Columbia Cancer Stem Cells Market By Type (2017-2022)

10.3.5.2.Columbia Cancer Stem Cells Market By End User (2017-2022)

10.3.5.     Rest of South America

10.3.5.1.Rest of South America Cancer Stem Cells Market and Growth Rate (2017-2022)

10.3.5.2.Rest of South America Cancer Stem Cells Market By Type (2017-2022)

10.3.5.2.Rest of South America Cancer Stem Cells Market By End User (2017-2022)

6.3.  Middle East and Africa

11.3.1.     Middle East and Africa Cancer Stem Cells Market and Growth Rate (2017-2022))

11.3.2.     Middle East and Africa Cancer Stem Cells Market By Type (2017-2022)

11.3.2.     Middle East and Africa Cancer Stem Cells Market By End User (2017-2022)

11.3.4.     Middle East and Africa Cancer Stem Cells Market By Country (2017-2022)

11.3.5.     Saudi Arabia

11.3.5.1.Saudi Arabia Cancer Stem Cells Market and Growth Rate (2017-2022)

11.3.5.2.Saudi Arabia Cancer Stem Cells Market By Type (2017-2022)

11.3.5.2.Saudi Arabia Cancer Stem Cells Market By End User (2017-2022)

11.3.5.     United Arab Emirates

11.3.5.1.United Arab Emirates Cancer Stem Cells Market and Growth Rate (2017-2022)

11.3.5.2.United Arab Emirates Cancer Stem Cells Market By Type (2017-2022)

11.3.5.2.United Arab Emirates Cancer Stem Cells Market By End User (2017-2022)

11.3.5.     South Africa

11.3.5.1.South Africa Cancer Stem Cells Market and Growth Rate (2017-2022)

11.3.5.2.South Africa Cancer Stem Cells Market By Type (2017-2022)

11.3.5.2.South Africa Cancer Stem Cells Market By End User (2017-2022)

11.3.5.     Rest of Middle East and Africa

11.3.5.1.Rest of Middle East and Africa Cancer Stem Cells Market and Growth Rate (2017-2022)

11.3.5.2.Rest of Middle East and Africa Cancer Stem Cells Market By Type (2017-2022)

11.3.5.2.Rest of Middle East and Africa Cancer Stem Cells Market By End User (2017-2022)

7.     Company Profiles

7.1.  Merck KGaA

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Bionomics

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Thermo Fisher Scientific Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  AbbVie Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Lonza

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Miltenyi Biotec

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  PromoCell GmbH

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Stemline Therapeutics

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  MacroGenics, Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  OncoMed Pharmaceuticals Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  STEMCELL Technologies Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Irvine Scientificand BIOTIME Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*